等级
pharmaceutical primary standard
API类
triamcinolone
制造商/商品名称
USP
应用
pharmaceutical (small molecule)
格式
neat
SMILES字符串
[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1(F)[C@@H](O)C[C@@]4(C)[C@@]2([H])C[C@H]5OC(C)(C)O[C@@]45C(=O)CO
InChI
1S/C24H31FO6/c1-20(2)30-19-10-16-15-6-5-13-9-14(27)7-8-21(13,3)23(15,25)17(28)11-22(16,4)24(19,31-20)18(29)12-26/h7-9,15-17,19,26,28H,5-6,10-12H2,1-4H3/t15-,16-,17-,19+,21-,22-,23-,24+/m0/s1
InChI key
YNDXUCZADRHECN-JNQJZLCISA-N
基因信息
human ... NR3C1(2908)
正在寻找类似产品? 访问 产品对比指南
一般描述
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
应用
Triamcinolone acetonide USP reference standard intended for use in specified quality tests and assays.
Also used to prepare system suitability, standard, and standard stock solution for assay, impurity analysis, and performance tests according to the given below monographs of United States Pharmacopeia (USP):
Also used to prepare system suitability, standard, and standard stock solution for assay, impurity analysis, and performance tests according to the given below monographs of United States Pharmacopeia (USP):
- Triamcinolone Hexacetonide
- Triamcinolone Acetonide Injectable Suspension
- Triamcinolone Acetonide Nasal Spray
分析说明
These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
其他说明
Sales restrictions may apply.
警示用语：
Danger
危险声明
危险分类
Acute Tox. 4 Oral - Repr. 1B
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
法规信息
监管及禁止进口产品
Triamcinolone Acetonide Nasal Spray
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 46(5) (2021)
Triamcinolone Acetonide Injectable Suspension
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 44(3), 4490-4490 (2020)
Triamcinolone Hexacetonide
United States Pharmacopeia and National Formulary
United States Pharmacopeia, 36(5), 4492-4492 (2020)
Jost B Jonas
Ophthalmic research, 38(4), 218-245 (2006-06-10)
Based on experimental studies and clinical observations by Robert Machemer, Gholam Peyman and others, the vitreous cavity has increasingly been used as a reservoir of drugs for the direct treatment of intraocular diseases. The most widely injected drug so far
Hui-Ping Qi et al.
Current eye research, 37(12), 1136-1147 (2012-07-17)
To compare the efficacy of intravitreal (IV) triamcinolone acetonide (IVTA) versus subtenon (ST) triamcinolone acetonide (STTA) injection for the treatment of diabetic macular edema (DME). Searches for randomized clinical trials published between 1 January 1950 and 15 March 2011 were
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门